J
Julie Veziant
Researcher at University of Auvergne
Publications - 42
Citations - 915
Julie Veziant is an academic researcher from University of Auvergne. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 9, co-authored 29 publications receiving 583 citations. Previous affiliations of Julie Veziant include Institut national de la recherche agronomique.
Papers
More filters
Journal ArticleDOI
Implémentation à grande échelle des programmes de réhabilitation améliorée en chirurgie. Une expérience francophone
TL;DR: La rehabilitation amelioree apres chirurgie (RAC) est une approche qui a depasse dans certaines specialites le stade de la recherche clinique and pose actuellement the problematique de l’implementation (deploiement) a grand echelle des programmes de RAC.
Journal ArticleDOI
Management of Pathogenic CDH1 Variant Carriers Within the FREGAT Network
Julie Veziant,Geneviève Belleannée,A. R. Bhattacharya,David H. Autor,Susan Rice,Ekinci, Arsen,Michael J. Joyner +6 more
TL;DR: In this paper , the authors describe the management of pathogenic CDH1 variant carriers (pCDH1vc) within the FREGAT (FRench Eso-GAsTric tumor) network.
Journal ArticleDOI
Management of Pathogenic CDH1 Variant Carriers Within the FREGAT Network
Capucine Bres,Thibault Voron,Leonor Benhaim,Damien Bergeat,Yann Parc,Mehdi Karoui,Laurent Genser,G. Péré,Jonathan Abraham Demma,Ophélie Bacoeur-Ouzillou,Gilles Lebreton,Jérémie Thereaux,Caroline Gronnier,Peggy Dartigues,Magali Svrcek,Guillaume Bouzillé,Armelle Bardier,Anne-Cécile Brunac,B Roche,Claude Darcha,Céline Bazille,Laurent Doucet,Geneviève Belleannée,Sophie Lejeune,Marie-Pierre Buisine,Florence Renaud,Frederiek Nuytens,Patrick R. Benusiglio,Julie Veziant,Clarisse Eveno,Guillaume Piessen +30 more
TL;DR: The risk of cancer among patients undergoing PTG remained high and unpredictable and has to be balanced with the morbidity and functional consequence of PTG, resulting in a dismal prognosis among pCDH1vc.
Journal ArticleDOI
Non-occlusive Small Bowel Ischemia Related to Postoperative Feeding Jejunostomy Tube Use After Esophagectomy for Cancer: Propensity Score Analysis of the AFC-FREGAT Database
Julie Veziant,Johan Gagnière,Caroline Gronnier,Christophe Mariette,Stylianos Tzedakis,D. Fuks,Guillaume Piessen,Guillaume Luc,Magalie Cabau,Jacques Jougon,Bogdan Badic,P Lozach,Serge Cappeliez,Gilles Lebreton,Arnaud Alves,Renaud Flamein,Denis Pezet,Federica Pipitone,Bogdan Stan Iuga,N. Contival,Eric Pappalardo,Styliani Mantziari,Flora Hec,Marguerite Vanderbeken,Williams Tessier,N. Briez,Fabien Fredon,Alain Gainant,Muriel Mathonnet,Jean-Marc Bigourdan,Salim Mezoughi,Christian Ducerf,Jacques Baulieux,Arnaud Pasquer,Oussama Baraket,Gilles Poncet,Delphine Vaudoyer,Peggy Jourdan Enfer,Laurent Villeneuve,Olivier Glehen,Thibault Coste,Jean-Michel Fabre,Frédéric Marchal,R Frisoni,Ahmet Ayav,Laurent Brunaud,Laurent Bresler,Charlotte Cohen,Olivier Aze,Nicolas Venissac,Daniel Pop,Jérôme Mouroux,I. Donici,Michel Prudhomme,Emanuele Felli,S. Lisunfui,M. Seman,Gaëlle Petit,Mehdi Karoui,Christophe Trésallet,Fabrice Menegaux,Laurent Hannoun,Brice Malgras,Denis Lantuas,Karine Pautrat,Marc Pocard,Patrice Valleur +66 more
TL;DR: Assessment of the impact of postoperative feeding JT on NOSBI occurrence after esophagectomy for cancer found enteral nutrition is more effective than parenteral nutrition with a faster bowel recovery, decrease in length of hospital stay, and postoperative weight loss.
Journal ArticleDOI
Innovation conceptuelle : la médecine 4P et la chirurgie 4P
TL;DR: The concept of la medecine 4P as discussed by the authors is proposed to be a preventive, predictive, and participative approach to the analysis of the human genome, which is a dominant approach in the field of medicine.